Annual report [Section 13 and 15(d), not S-K Item 405]

FINANCIAL INSTRUMENTS (Tables)

v3.26.1
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2025
FINANCIAL INSTRUMENTS  
Schedule of derivatives instruments statements of financial performance and financial position, location

The fair value of the Company’s open contracts as well as closed contracts that had not yet settled is recorded in the Consolidated Balance Sheets as follows (in thousands):

December 31, 

2025

2024

Prepaid expenses and other current assets

$

318

$

868

Other assets

 

 

4,150

Accrued liabilities

 

 

3,731

The impact of commodity derivative contracts on the Consolidated Statements of Operations was as follows (in thousands):

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Realized (gain) loss (1)

$

(16,256)

$

(2,879)

$

4,087

Unrealized loss (gain)

2,663

(710)

(58,846)

Derivative gain, net

$

(13,593)

$

(3,589)

$

(54,759)

(1) Includes $11.9 million related to the monetization of the Company’s natural gas put contracts and costless collar during 2025.
Schedule of net values and estimated fair values of the Company's debt

The following table presents the net values and estimated fair values of the Company’s debt (in thousands):

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

Net Value

  ​ ​ ​

Fair Value

  ​ ​ ​

Net Value

  ​ ​ ​

Fair Value

Term Loan

$

$

$

112,132

$

109,727

11.75% Notes

 

 

272,081

 

278,765

10.75% Notes

342,355

320,208

TVPX Loan

8,458

8,613

9,010

9,395

Total

$

350,813

$

328,821

$

393,223

$

397,887